Dynein light chain LC8-type 1 pseudogene 4 (DYNLL1P4)

DYNLL1P4 is a processed pseudogene of the dynein light chain LC8-type 1 (DYNLL1) gene. Processed pseudogenes, such as DYNLL1P4, originate from retrotransposition events and are unable to encode functional proteins due to loss of coding potential, accumulation of mutations, or truncation[2][6]. While parental genes (like DYNLL1) are involved in critical cellular processes—such as microtubule dynamics, intracellular transport, mitosis, and apoptosis—pseudogenes like DYNLL1P4 typically do not produce functional protein and are not considered therapeutic targets, enzymes, receptors, or transporters[2][6]. Pseudogenes may sometimes be transcribed and play regulatory roles at the RNA level, but there is no evidence for such activity specific to DYNLL1P4[2][6]. Thus, DYNLL1P4 should not be considered a drug target or included in lists of therapeutic targets. Key reasons this entry is not a therapeutic target: - It is a pseudogene and not capable of producing functional protein[6]. - No validated functional, regulatory, or disease-modifying role is established for DYNLL1P4 in the literature[2][6]. - There are no associated drugs, biomarker relevance, or safety concerns. If you intended to refer to the functional protein-coding gene, the correct target would be Dynein light chain LC8-type 1 (DYNLL1), not DYNLL1P4.